Sort
130,381 grants matching “hiv”
Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contacts
$1,177,109Timothy R Sterling · Vanderbilt University Medical Center · R01 · FY2022 · AI
Genotoxicity and mitochondrial toxicity of antiretroviral NRTI and PI drugs
$1,176,940Miriam C Poirier · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Mechanisms Of HIV-1 Induced Cell Death and Latency Formation in CD4+ Lymphocytes
$1,176,839John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)
$1,176,834Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
TRACKING HIV INFECTION AND ALCOHOL ABUSE CNS COMORBIDITY WITH NEUROIMAGING
$1,176,789Adolf Pfefferbaum · Sri International · U01 · FY2010 · AA
Driving Medical Projects (4 of 4)
$1,176,777Edward Mark Scolnick · Massachusetts Institute Of Technology · RL1 · FY2008 · GM
VS4A: VITAL Start (Video-Intervention to Inspire Treatment Adherence for Life) for Adolescents, a video intervention to improve retention and adherence to ART among adolescents living with HIV
$1,176,748Saeed Ahmed · Baylor College Of Medicine · UG1 · FY2023 · MD
Clinical Trials of Patients with AIDS-Related Malignancies
$1,176,741Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Infections, immunity, and inflammation in cancer
$1,176,615Eric A Engels · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA
DNA Vaccines
$1,176,511George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
COLUMBIA-ADARC AIDS CLINICAL TRIALS UNIT
$1,176,475Columbia University Health Sciences · U01 · FY2000 · AI
An unbiased OMICs approach to identify mechanisms of Cocaine regulation of the HIV reservoir.
$1,176,111Rafick-Pierre Sekaly · Case Western Reserve University · R01 · FY2019 · DA
Molecular and Cellular Biology of HIV Encephalopathy
$1,176,014University Of Pennsylvania · P01 · FY2005 · NS
Defining the impact of drug use on immune function and fitness against HIV-1
$1,176,000Alex K Shalek · Massachusetts General Hospital · DP1 · FY2025 · DA
Neural Immunity in HIV Dementia
$1,176,000Howard Eliot Gendelman · University Of Nebraska Medical Center · P01 · FY2009 · NS
Defining the impact of drug use on immune function and fitness against HIV-1
$1,176,000Alex K Shalek · Massachusetts General Hospital · DP1 · FY2023 · DA
Defining the impact of drug use on immune function and fitness against HIV-1
$1,176,000Alex K Shalek · Massachusetts General Hospital · DP1 · FY2021 · DA
Defining the impact of drug use on immune function and fitness against HIV-1
$1,176,000Alex K Shalek · Massachusetts General Hospital · DP1 · FY2024 · DA
Defining the impact of drug use on immune function and fitness against HIV-1
$1,176,000Alex K Shalek · Massachusetts General Hospital · DP1 · FY2022 · DA
Neural Immunity in HIV Dementia
$1,176,000Howard Eliot Gendelman · University Of Nebraska Medical Center · P01 · FY2008 · NS
Novel Therapeutics HIV-associated Cognitive Disorders
$1,175,971Justin C McArthur · Johns Hopkins University · P30 · FY2008 · MH
Center for AIDS Intervention Research Core Support
$1,175,701Jeffrey A. Kelly · Medical College Of Wisconsin · P30 · FY2018 · MH
Characterization of immunogenic and structural properties of HIV-1 envelope
$1,175,614Michael W Cho · Case Western Reserve University · P01 · FY2008 · AI
Evolution of antiviral resistance mutations and their biological and biophysical implications
$1,175,609Ronald Levy · Seattle Children'S Hospital · U54 · FY2021 · AI
Drug Use, Disorder & HIV/AIDS Risk in Juvenile Justice Youth:A Longitudinal Study
$1,175,105Linda A Teplin · Northwestern University At Chicago · R01 · FY2009 · DA